133 related articles for article (PubMed ID: 26735908)
1. Synthesis, vasorelaxant activity and 2D-QSAR study of some novel pyridazine derivatives.
George RF; Saleh DO
Eur J Med Chem; 2016 Jan; 108():663-673. PubMed ID: 26735908
[TBL] [Abstract][Full Text] [Related]
2. Rational design, synthesis and 2D-QSAR study of novel vasorelaxant active benzofuran-pyridine hybrids.
Srour AM; Abd El-Karim SS; Saleh DO; El-Eraky WI; Nofal ZM
Bioorg Med Chem Lett; 2016 May; 26(10):2557-2561. PubMed ID: 27048942
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and vasodilator activity of some pyridazin-3(2
Allam HA; Kamel AA; El-Daly M; George RF
Future Med Chem; 2020 Jan; 12(1):37-50. PubMed ID: 31710239
[No Abstract] [Full Text] [Related]
4. Synthesis and 2D-QSAR Study of Active Benzofuran-Based Vasodilators.
Khalifa NM; Srour AM; Abd El-Karim SS; Saleh DO; Al-Omar MA
Molecules; 2017 Oct; 22(11):. PubMed ID: 29072621
[TBL] [Abstract][Full Text] [Related]
5. Rational design, synthesis and QSAR study of vasorelaxant active 3-pyridinecarbonitriles incorporating 1H-benzimidazol-2-yl function.
Nofal ZM; Srour AM; El-Eraky WI; Saleh DO; Girgis AS
Eur J Med Chem; 2013 May; 63():14-21. PubMed ID: 23454530
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and structure-activity relationships of new phthalazinedione derivatives with vasorelaxant activity.
Munín J; Quezada E; Cuiñas A; Campos-Toimil M; Uriarte E; Santana L; Viña D
Eur J Med Chem; 2014 Jul; 82():407-17. PubMed ID: 24929291
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 2-substituted-6-phenyl-4,5-dihydropyridazin-3(2H)-ones as potent inodilators.
Kumar D; Carron R; La Calle CD; Jindal DP; Bansal R
Acta Pharm; 2008 Dec; 58(4):393-405. PubMed ID: 19103574
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Molecular Modeling of Novel Substituted Pyridazinones and their Vasorelaxant Activities.
Ismail MMF; Soliman DHS; Elmoniem MHA; Jaleel GAA
Med Chem; 2021; 17(2):171-186. PubMed ID: 32216740
[TBL] [Abstract][Full Text] [Related]
9. Pyridazine derivatives XIV. Study of the vasorelaxant action of 6-aryl-5-piperidino-3-hydrazinopyridazines in isolated rat thoracic aorta: comparison with hydralazine.
Campos-Toimil M; Estévez I; Raviña E; Orallo F
Gen Pharmacol; 1998 Feb; 30(2):201-7. PubMed ID: 9580127
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and vasodilatory activity of some amide derivatives of 6-(4-carboxymethyloxyphenyl)-4,5-dihydro-3(2H)-pyridazinone.
Bansal R; Kumar D; Carron R; de la Calle C
Eur J Med Chem; 2009 Nov; 44(11):4441-7. PubMed ID: 19589624
[TBL] [Abstract][Full Text] [Related]
11. Pyridazinone derivatives: design, synthesis, and in vitro vasorelaxant activity.
Abouzid K; Abdel Hakeem M; Khalil O; Maklad Y
Bioorg Med Chem; 2008 Jan; 16(1):382-9. PubMed ID: 17905589
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, ex vivo and in silico studies of 3-cyano-2-pyridone derivatives with vasorelaxant activity.
Hernández F; Sánchez A; Rendón-Vallejo P; Millán-Pacheco C; Alcaraz Y; Delgado F; Vázquez MA; Estrada-Soto S
Eur J Med Chem; 2013; 70():669-76. PubMed ID: 24212125
[TBL] [Abstract][Full Text] [Related]
13. Flavonoids as vasorelaxant agents: synthesis, biological evaluation and quantitative structure activities relationship (QSAR) studies.
Dong X; Wang Y; Liu T; Wu P; Gao J; Xu J; Yang B; Hu Y
Molecules; 2011 Sep; 16(10):8257-72. PubMed ID: 21959298
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and vasorelaxant evaluation of novel 7-methoxyl-2,3-disubstituted-quinoxaline derivatives.
Zheng CB; Gao WC; Pang PP; Ma X; Peng LC; Yang L; Li X
Bioorg Med Chem Lett; 2021 Mar; 36():127785. PubMed ID: 33444740
[TBL] [Abstract][Full Text] [Related]
15. Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives.
Kümmerle AE; Raimundo JM; Leal CM; da Silva GS; Balliano TL; Pereira MA; de Simone CA; Sudo RT; Zapata-Sudo G; Fraga CA; Barreiro EJ
Eur J Med Chem; 2009 Oct; 44(10):4004-9. PubMed ID: 19500884
[TBL] [Abstract][Full Text] [Related]
16. Solid-phase synthesis and evaluation of libraries of substituted 4,5-dihydropyridazinones as vasodilator agents.
Gouault N; Martin-Chouly CA; Lugnier C; Cupif JF; Tonnelier A; Feger F; Lagente V; David M
J Pharm Pharmacol; 2004 Aug; 56(8):1029-37. PubMed ID: 15285848
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of n-butylphthalide derivatives.
Wang W; Cha XX; Reiner J; Gao Y; Qiao HL; Shen JX; Chang JB
Eur J Med Chem; 2010 May; 45(5):1941-6. PubMed ID: 20133025
[TBL] [Abstract][Full Text] [Related]
18. Benzofuran-morpholinomethyl-pyrazoline hybrids as a new class of vasorelaxant agents: synthesis and quantitative structure-activity relationship study.
Hassan GS; Rahman DE; Abdel Saleh DO; Abdel Jaleel GA
Chem Pharm Bull (Tokyo); 2014; 62(12):1238-51. PubMed ID: 25450632
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and vasorelaxant evaluation of novel coumarin-pyrimidine hybrids.
Amin KM; Awadalla FM; Eissa AA; Abou-Seri SM; Hassan GS
Bioorg Med Chem; 2011 Oct; 19(20):6087-97. PubMed ID: 21908192
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel hybrid chalcone derivatives as vasorelaxant agents.
Dong X; Du L; Pan Z; Liu T; Yang B; Hu Y
Eur J Med Chem; 2010 Sep; 45(9):3986-92. PubMed ID: 20566231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
